BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 37445988)

  • 1. Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.
    Salamini-Montemurri M; Lamas-Maceiras M; Lorenzo-Catoira L; Vizoso-Vázquez Á; Barreiro-Alonso A; Rodríguez-Belmonte E; Quindós-Varela M; Cerdán ME
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer.
    Wang H; Fu Z; Dai C; Cao J; Liu X; Xu J; Lv M; Gu Y; Zhang J; Hua X; Jia G; Xu S; Jia X; Xu P
    Sci Rep; 2016 Dec; 6():38983. PubMed ID: 27941916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
    Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
    Dong S; Wang R; Wang H; Ding Q; Zhou X; Wang J; Zhang K; Long Y; Lu S; Hong T; Ren H; Wong K; Sheng X; Wang Y; Zeng Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):110. PubMed ID: 30823895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z; Zhu X; Teng Y
    Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.
    Lin X; Tang X; Zheng T; Qiu J; Hua K
    J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/
    Xie M; Fu Q; Wang PP; Cui YL
    Dis Markers; 2021; 2021():1405045. PubMed ID: 34790276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells.
    Qiu J; Ye L; Ding J; Feng W; Zhang Y; Lv T; Wang J; Hua K
    J Steroid Biochem Mol Biol; 2014 May; 141():60-70. PubMed ID: 24380700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
    Li YW; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
    [No Abstract]   [Full Text] [Related]  

  • 14. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.
    Ning L; Long B; Zhang W; Yu M; Wang S; Cao D; Yang J; Shen K; Huang Y; Lang J
    Int J Oncol; 2018 Dec; 53(6):2637-2646. PubMed ID: 30272264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
    Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
    Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
    Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.